X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32263) 32263
Newsletter (2497) 2497
Book Chapter (574) 574
Newspaper Article (526) 526
Magazine Article (155) 155
Book / eBook (90) 90
Dissertation (43) 43
Web Resource (13) 13
Publication (12) 12
Conference Proceeding (11) 11
Trade Publication Article (10) 10
Reference (8) 8
Book Review (5) 5
Transcript (3) 3
Government Document (2) 2
Journal / eJournal (2) 2
Streaming Video (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22846) 22846
science & technology (20858) 20858
life sciences & biomedicine (19979) 19979
male (15439) 15439
diabetes (13637) 13637
female (13492) 13492
middle aged (10750) 10750
adult (8307) 8307
endocrinology & metabolism (7478) 7478
aged (7177) 7177
diabetic nephropathies (7155) 7155
risk factors (6649) 6649
diabetes mellitus (6066) 6066
animals (5685) 5685
diabetes mellitus, type 2 - complications (5356) 5356
type 2 diabetes (5313) 5313
diabetics (5188) 5188
diabetic nephropathy (5170) 5170
research (5026) 5026
diabetic retinopathy (4643) 4643
care and treatment (3616) 3616
diabetes mellitus, type 1 - complications (3318) 3318
diabetic nephropathies - complications (3136) 3136
analysis (3120) 3120
diabetic nephropathies - physiopathology (3067) 3067
urology & nephrology (3039) 3039
diabetic nephropathies - etiology (2851) 2851
kidney diseases (2837) 2837
glucose (2827) 2827
health aspects (2778) 2778
blood pressure (2670) 2670
rats (2478) 2478
hypertension (2449) 2449
medical research (2401) 2401
type 1 diabetes (2388) 2388
medicine & public health (2378) 2378
abridged index medicus (2316) 2316
adolescent (2198) 2198
complications and side effects (2183) 2183
diabetic nephropathies - metabolism (2146) 2146
development and progression (2140) 2140
diabetic nephropathies - drug therapy (2125) 2125
diabetic nephropathies - pathology (2109) 2109
medicine, experimental (2057) 2057
internal medicine (2046) 2046
diabetes mellitus, type 2 - blood (2020) 2020
nephropathy (2015) 2015
hyperglycemia (2005) 2005
blood glucose - metabolism (1967) 1967
oxidative stress (1959) 1959
studies (1938) 1938
disease progression (1895) 1895
diabetes mellitus, type 2 - physiopathology (1873) 1873
diabetic nephropathies - prevention & control (1872) 1872
medicine (1860) 1860
diabetic nephropathies - epidemiology (1848) 1848
glomerular filtration rate (1836) 1836
general & internal medicine (1832) 1832
mortality (1829) 1829
research article (1813) 1813
insulin (1812) 1812
medicine, general & internal (1812) 1812
diabetic nephropathies - blood (1802) 1802
time factors (1798) 1798
diabetes complications (1780) 1780
cardiovascular disease (1767) 1767
mice (1730) 1730
follow-up studies (1664) 1664
diabetes mellitus, type 2 - drug therapy (1654) 1654
proteins (1626) 1626
cross-sectional studies (1618) 1618
prevalence (1605) 1605
treatment outcome (1601) 1601
diabetic nephropathies - therapy (1598) 1598
patients (1575) 1575
physiological aspects (1559) 1559
diabetic nephropathies - diagnosis (1554) 1554
albuminuria (1541) 1541
rodents (1531) 1531
diabetic neuropathy (1521) 1521
chronic kidney failure (1510) 1510
diabetic nephropathies - genetics (1496) 1496
kidneys (1494) 1494
diabetes mellitus, type 1 - physiopathology (1487) 1487
aged, 80 and over (1484) 1484
diabetes therapy (1482) 1482
cardiovascular system & cardiology (1466) 1466
retrospective studies (1426) 1426
hypoglycemic agents - therapeutic use (1409) 1409
complications (1394) 1394
inflammation (1392) 1392
prospective studies (1380) 1380
prognosis (1374) 1374
medicine, research & experimental (1371) 1371
research & experimental medicine (1371) 1371
diabetes mellitus, type 1 - blood (1368) 1368
case-control studies (1356) 1356
nephrology (1339) 1339
glycated hemoglobin a - analysis (1337) 1337
pharmacology & pharmacy (1293) 1293
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (36) 36
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Theses (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34549) 34549
German (440) 440
Japanese (354) 354
French (328) 328
Spanish (265) 265
Russian (178) 178
Polish (124) 124
Italian (116) 116
Chinese (112) 112
Portuguese (109) 109
Czech (71) 71
Korean (63) 63
Hungarian (34) 34
Danish (23) 23
Swedish (21) 21
Romanian (20) 20
Dutch (19) 19
Croatian (15) 15
Bulgarian (13) 13
Slovak (13) 13
Finnish (11) 11
Hebrew (10) 10
Serbian (10) 10
Turkish (10) 10
Arabic (7) 7
Persian (7) 7
Ukrainian (7) 7
Norwegian (6) 6
Greek (3) 3
Indonesian (2) 2
Bosnian (1) 1
Georgian (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, ISBN 9783319088730, xv, 129 pages
An overview of the diagnosis, treatment, and long-term management of diabetic-related kidney disease in clinical practice. Includes an evidence-based... 
Diabetic Nephropathies | diagnosis | therapy | Nephrology | Medicine | Diabetes | Medicine & Public Health | Diabetic nephropathies
Book
Diabetes, obesity & metabolism, ISSN 1462-8902, 06/2018, Volume 20, Issue 6, pp. 1369 - 1376
...), with a large variability between patients. We are assessing its effect on renal outcomes in the Study Of diabetic Nephropathy with AtRasentan (SONAR; NCT01858532... 
ANTAGONIST | INHIBITION | ALBUMINURIA | PREDICTORS | HEART-FAILURE | MULTIPLE RISK MARKERS | CHRONIC KIDNEY-DISEASE | diabetic kidney disease | endothelin receptor antagonist | randomized controlled clinical trial | atrasentan | personalized medicine | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Humans | Diabetic Nephropathies - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - drug therapy | Drug Therapy, Combination - adverse effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adult | Endothelin A Receptor Antagonists - adverse effects | Female | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Endothelin A Receptor Antagonists - therapeutic use | Kidney - physiopathology | Precision Medicine | Severity of Illness Index | Kidney - drug effects | Double-Blind Method | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Randomized Controlled Trials as Topic | Kidney Failure, Chronic - prevention & control | Kidney Failure, Chronic - complications | Atrasentan - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Atrasentan - adverse effects | Research Design | Type 2 diabetes | Antimitotic agents | Medical research | Endothelin | Chronic kidney failure | Diabetic nephropathies | Angiotensin | Clinical trials | Albumin | Medicine, Experimental | Antineoplastic agents | Risk factors | Creatinine | Renin | Nephropathy | Kidneys | Diabetes mellitus | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Patients | Index Medicus | Clinical Trial Design
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2019, Volume 380, Issue 24, pp. 2295 - 2306
This double-blind, randomized trial compared canagliflozin with placebo in patients with type 2 diabetes and evidence of kidney disease that was treated with... 
KIDNEY-DISEASE | EMPAGLIFLOZIN | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Glomerular Filtration Rate | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Canagliflozin - adverse effects | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - blood | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Myocardial infarction | End-stage renal disease | Laboratories | Hemodialysis | Clinical trials | Immunosuppressive agents | Clinical outcomes | Renin | Amputation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Creatinine | Cerebral infarction | Enzymes | Kidneys | Diabetes mellitus | Glomerular filtration rate | Nephropathy | Sodium | Collaboration | Angiotensin | Renal failure | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, ISSN 1871-4021, 2016, Volume 10, Issue 4, pp. 247 - 249
.... Although various therapeutic approaches, such as hypoglycemic agents, antihypertensive drugs, and renin-angiotensin system inhibitors, have been tried to slow the progression of nephropathy... 
Endocrinology & Metabolism | Diabetic Nephropathies - complications | Humans | Kidney Failure, Chronic - etiology | Complications and side effects | Diabetic nephropathies | Research | Index Medicus
Journal Article
Nature reviews. Nephrology, ISSN 1759-5061, 2014, Volume 10, Issue 9, pp. 517 - 530
Journal Article